Transcriptomics

Dataset Information

0

Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE228924 | GEO | 2023/05/04

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies II
2023-05-04 | GSE228922 | GEO
Transcriptomics Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies I
2023-05-04 | GSE228921 | GEO
Unknown Feature-based learning improves adaptability without compromising precision.
| S-EPMC5700946 | biostudies-literature
Unknown CAR T-Cell Therapy in Hematological Malignancies.
| S-EPMC8396650 | biostudies-literature
Unknown Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer.
| S-EPMC7321378 | biostudies-literature
Unknown Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
| S-EPMC7713173 | biostudies-literature
Unknown Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas.
| S-EPMC5050151 | biostudies-literature
Unknown Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies.
| S-EPMC7697548 | biostudies-literature
Transcriptomics Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
2022-03-09 | GSE192998 | GEO
Unknown Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.
| S-EPMC7819297 | biostudies-literature